Kate Vandyke

Dr. Kate Vandyke is a Research Fellow (with PhD) at the University of Adelaide's School of Biomedicine, based at the South Australian Health and Medical Research Institute (SAHMRI) within the Precision Medicine Theme. She leads the Myeloma Research Laboratory and focuses on elucidating molecular and cellular mechanisms driving multiple myeloma progression, particularly in high-risk patient subgroups. Her work emphasizes identifying biomarkers, optimizing drug delivery strategies, and discovering novel therapeutic targets to address treatment resistance and relapse.

Education and Research Interests: Her research integrates cutting-edge techniques like CRISPR gRNA screens and metabolomics to pinpoint metabolic vulnerabilities in myeloma tumors. Key projects include studying myeloma dissemination, microenvironmental interactions, and serum biomarker identification for early disease detection. She collaborates with institutions like the German National Reference Centre for Streptococci for large-scale isolate analysis.

Grants and Supervision: Dr. Vandyke is eligible to supervise PhD and Honours students in projects focusing on multiomic approaches to myeloma vulnerabilities. Her lab offers opportunities in Semester 1 and 2, emphasizing translational research and clinical relevance.

Labs and Teams: She heads the Myeloma Research Laboratory at SAHMRI, focusing on precision medicine strategies for high-risk myeloma. Her work bridges basic science and clinical applications, with a strong emphasis on drug delivery innovation and personalized treatment approaches.